Hide
Show all
Email this article 
Post a Comment 
Hemostasis in Pregnancy Induced Hypertension (PIH)
Abstract
Background: Pregnancy is a hypercoagulable state as the parturient is physiologically prepared against haemorrhage. Plasma fibrinogen level increases and platelet count decreases. Pregnancy induced Hypertension (PIH) is a syndrome complex of hypertension, oedema and proteinuria. In PIH, the physiological changes that occur in normal pregnancy are further aggravated and the woman is prone to develop Disseminated Intravascular Coagulation (DIC) which is a chief pathogenic factor in PIH.
Objective: 1.To estimate platelet count and serum fibrinogen in normal pregnant women and women with PIH.2.To do bleeding time and clotting time in normal pregnant women & women with PIH& compare both.
Material & methods: Two groups of pregnant women were involved. The first group (control) comprises normal pregnant women. The study group consists of pregnant women with PIH. Platelet count was done by direct method. Serum Fibrinogen was estimated by Rapid Turbidimetric method. Bleeding time was measured by Duke Method & Clotting time was measured by Wright’s capillary tube method. Statistical analysis was done using appropriate student t test & SD.
Results: In PIH group, platelet count is moderately reduced (Mean 1.72, P=< 0.05) and bleeding time is prolonged (mean 117.45, P0.001), Serum fibrinogen level is reduced (mean 237.14, P 0.001) and clotting time is prolonged(mean 16.9,P 0.001).
Conclusion: Pregnant women with PIH are more prone to develop coagulation abnormalities which may result in bleeding tendency. Hence, serial estimations of platelet count & bleeding time can be used to assess primary hemostatic function. Plasma fibrinogen level &clotting time measurement may be used to assess secondary hemostatic function.
Keywords
Full Text:
PDFReferences
. Billet HH. Thrombocytopenia in pregnancy. J Assoc- Acad-Minor-Phys. 1994; 5(3): 117-22.
. Bonnar J, Redman CW, Denson KW. The role of coagulation and fibrinolysis in Preeclampsia. Perspect Nephrol Hypertens 1976; 5; 85-93.
. Borok Z, Weitz J, Owen J, Auerbach M, Nossel HL. Fibrinogen proteolysis and platelet alpha- granule release in preeclampsia/eclampsia. Blood 1984; 6393: 525-31.
. Burrows RF, Hunter DJ, Andrew M, Kelton JG. A prospective study investigating the mechanism of thrombocytopenia in Preeclampsia. Obstet Gynecol. 1987; 70 (3pt 1): 334-8.
. Dube B, Bhattacharya S, DubeRK,Blood coagulation profile in Indian patients with Pre-eclampsia and eclampsia. Br. J Obstet and Gynaecol 1975; 82; 35-39.
. Graeff H, Von Hugo R, Schrcock R. Recent aspects of hemostasis, hematology and hemorheology in Preeclampsia and eclampsia. Eur J Obstet and Gynaecol Reprod Biol 1984; 17:91-102.
. Jambhulkar S, Shrinkhande A, Shrivastava R, Deshmukh K. Coagulation profile in Pregnancy Induced Hypertension. Indian Journal of Hematology & Blood Transfusion 2001; XIX (1).
. Kanfer A, Bruch JF, Nguyen G, He CJ, Delarue F, Flahault A, Nessmann C, Uzan S. Increased placental antifibrinolytic potential and fibrin deposits in Pregnancy Induced Hypertension and Preeclampsia. Lab Invest 1996; 74; 253-8.
. Keith D. Edmonds Dewhurst’s Textbook of Obstetrics and Gynaecology for postgraduates sixth edition, 1988.
. Kelton JG, Hunbter DJ, Neame PB. A platelet function defect in Preeclampsia. Obstet Gynecol 1985; 65(1); 107-9.
. Letsky EA. Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol. 2001; 15(4): 623-44.
. Maki M. Coagulation, fibrinolysis, platelet and Kinin-forming systems during toxaemia of pregnancy. Biol Res pregnancy Perinatal 1983; 4(4); 152-4.
. Metz J, Cincotta R, Francis M, De Rosa L, Balloch A. Screening for consumptive coagulipathy in Preeclampsia. Int J Gynaecol Obstet 1994; 461(1): 3-9.
. Mjahed K, Hammamouchi B, Hammoudi D, Harti A, Miguil M, Barrou L. Critical analysis of hemostasis disorders in the course of eclampsia. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1998; 27(6); 607-10.
. Perry KG Jr, Martin JN Jr. Abnormal hemostasis and coagulopathy in preeclampsia eclampsia. Clinical obstetrics & Gynecology 1992; 35(2): 338-50.
. Romero R, Mazor M, Lockwood CJ, Emamian M Belanger KP, Hobbins JC, Duffy T. Clinical significance, Prevalence and natural history of thrombocytopenia in Pregnancy-induced hypertension. Am J Perinatol, 1989; 6(1): 32-8.
. Stella A, Babbo GL, Grella PV. Endothelial damage and blood coagulation activation in preeclampsia. Minerva Gynecologica 1998; 50(11): 463-8.
. Vigil-De Gracia P. Pregnancy complicated by Pre-eclampsia-eclampsia with HELLP syndrome. International Journal of Gynaecology & Obstetrics. 2001; 72(1): 17-23.
. Weenink GH, Ten Cate JW, Treffers PE, Smorenberg-Schoorl ME. Blood coagulation in Pregnancy induced hypertension. Scand J Clin Lab Invest Suppl. 1985; 178: 99-105.
DOI: http://dx.doi.org/10.7439/ijbar.v8i6.4203
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 International Journal of Biomedical and Advance Research
This work is licensed under a Creative Commons Attribution 4.0 International License.